Pankaj Mistry

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 1K citations · Full text

Medicine, Oncology, Radiation Oncology +12

Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

Adam D. Cohen, María‐Victoria Mateos, Yaël C. Cohen et al. · Blood · 2022 · 201 citations · Full text

Medicine, Hematology, Oncology +17

Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

María Vieito, Víctor Moreno, Anna Spreafico et al. · Clinical Cancer Research · 2023 · 77 citations

Medicine, Pharmacokinetics, Pharmacology +17

Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation

Julie Bruce, Bruno Mazuquin, Alastair Canaway et al. · BMJ · 2021 · 72 citations · Full text

Medicine, Rehabilitation Medicine, Surgery +17

537MO First-in-human study of JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced cancers

Anna Spreafico, Víctor Moreno, Irene Braña et al. · Annals of Oncology · 2020 · 31 citations

Medicine, Oncology, Pharmacology +5